Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-27 @ 11:36 PM
Study NCT ID:
NCT06199934
Status:
COMPLETED
Last Update Posted:
2025-09-10
First Post:
2023-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
Status:
COMPLETED
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to learn about how well different versions of the Pfizer-BioNTech COVID-19 vaccine (called BNT162b2) work at preventing death, severe COVID-19 that requires a trip to the hospital, and overall use of healthcare resources, such as needing to go the doctor or urgent care due to illness. Pfizer is not enrolling any participants for this study. Instead, existing data from different health data sources will be used to help answer the scientific questions Pfizer is interested in learning more about.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| RAVEN | OTHER | Alias Study Number | View |